Cargando…
Long-term outcome of intravitreal anti-vascular endothelial growth factor treatment for pachychoroid neovasculopathy
To compare the long-term effectiveness of intravitreal anti-vascular endothelial growth factor (VEGF) treatment for pachychoroid neovasculopathy (PNV), polypoidal choroidal vasculopathy/aneurysmal type 1 neovascularization (PCV/AT1), and typical neovascular age-related macular degeneration (nAMD). F...
Autores principales: | Yoon, Jihyun, Yoon, Wontae, Na, Seung kwan, Lee, Jihyun, Kim, Chul Gu, Kim, Jong Woo, Cho, Han Joo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8187411/ https://www.ncbi.nlm.nih.gov/pubmed/34103603 http://dx.doi.org/10.1038/s41598-021-91589-2 |
Ejemplares similares
-
Author Correction: Long-term outcome of intravitreal anti-vascular endothelial growth factor treatment for pachychoroid neovasculopathy
por: Yoon, Jihyun, et al.
Publicado: (2021) -
Intravitreal aflibercept and ranibizumab for pachychoroid neovasculopathy
por: Jung, Byung Ju, et al.
Publicado: (2019) -
Impact of macular fluid features on outcomes of anti-vascular endothelial growth factor treatment for type 3 macular neovascularization
por: Yoon, Wontae, et al.
Publicado: (2021) -
Characteristics of pachychoroid neovasculopathy
por: Tagawa, Miho, et al.
Publicado: (2020) -
The implications of subretinal fluid in pachychoroid neovasculopathy
por: Lee, Geun Woo, et al.
Publicado: (2021)